Improving emergency treatment for prolonged seizures
Official title: Prehospital Management of Status Epilepticus
Funded at University of California, San Francisco · NIH-11001643 · Data updated 2026-11-12
This study looks at how emergency medical teams treat prolonged seizures, called status epilepticus, and aims to find out why they sometimes don't use important medications, like benzodiazepines, so they can improve care for patients having these serious seizures.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | April 1, 2020 |
| Project end | March 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $53,999 |
| NIH project number | 3K23NS116128-05S1 |
| Project ID | NIH-11001643 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who experience status epilepticus or are at risk of having prolonged seizures.
✕Less likely to help
Patients with seizure disorders that do not involve status epilepticus may not benefit from this research.
What this research studies
This research investigates how emergency medical services (EMS) manage status epilepticus, a severe condition characterized by prolonged seizures. It aims to identify the reasons behind the inconsistent use of benzodiazepines, which are critical for treating this condition, and to understand how these practices affect patient outcomes. By analyzing detailed EMS electronic medical records linked to hospital data, the study seeks to uncover factors that influence treatment decisions and ultimately improve care for patients experiencing status epilepticus.
Why it matters
Potential benefit: If successful, this research could lead to better prehospital treatment protocols, reducing morbidity and mortality associated with status epilepticus.
How similar studies have gone: Previous research has shown that improving EMS protocols can enhance patient outcomes in emergency situations, suggesting that this approach has potential for success.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Guterman, Elan — University of California, San Francisco
- Study coordinator: Guterman, Elan
Related research
Other NIH-funded projects on the same topics.
-
Microglia Help Finish Seizures and Heal the Brain
Scientists are studying how brain immune cells (microglia) help end severe seizures and repair brain damage, with potential new ideas for people who have had status epilepticus.
-
ARISEN Network pilot funding to advance autoimmune encephalitis and NORSE care
A pilot grants program within the ARISEN network offers small funding to researchers to speed up clinical trials and improve management and treatment of autoimmune encephalitis, Rasmussen syndrome, and NORSE.
-
ARISEN Network: Better Diagnosis and Treatment for Autoimmune Brain Inflammation in Children
A large team at Emory is building ways to diagnose autoimmune brain inflammation in kids earlier and tailor treatments to improve outcomes.
-
ARISEN Network: Patient-centered outcomes in autoimmune brain inflammation and status epilepticus
A nationwide registry study from Emory will collect patient- and caregiver-reported outcomes to understand how neuroinflammatory brain diseases affect people and what helps them most.
-
ARISEN: A regional network to understand autoimmune brain diseases in kids
A national, multi-center effort follows children with autoimmune brain diseases to better understand how their condition progresses and how it affects thinking and everyday life.
-
ARISEN: Advancing research on autoimmune brain diseases and neuroinflammation
This grant supports a Career Enhancement Core to train the next generation of clinician-scientists studying autoimmune brain diseases like autoimmune encephalitis, Rasmussen’s syndrome, and NORSE, with a focus on pediatric cases.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.